Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1986-12-17
|
pubmed:abstractText |
Peripheral blood lymphocytes were obtained from 65 individuals: 34 nondiabetic patients with islet cell autoantibodies (ICA) (prediabetic phase), 9 patients with newly diagnosed insulin-dependent diabetes mellitus (IDDM), 6 ICA-negative siblings or offsprings of IDDM patients, and 16 ICA-negative controls. The presence of lymphocyte abnormalities and/or activation was examined with dual fluorescence flow cytometry. The percentages of B cells, total T-lymphocyte, and helper T-lymphocyte (Th) and cytotoxic/suppressor T-lymphocyte (Tc/s) subsets and their ratio were not significantly different among the patient groups. No increased expression of interleukin 2 receptor on T-lymphocyte was found in newly diagnosed IDDM or prediabetic individuals. Sixteen of 49 patients had significantly increased number of T-lymphocyte expressing HLA-DR. A significant increase in the number of both Th and Tc/s subsets expressing HLA-DR was found in only 3 of 16 patients. This increase was unrelated to the patients's relative ICA titer or HLA-DR phenotype. On the other hand, the relative density of the DR antigen (RAD-DR) was significantly increased on both Th (886 +/- 120) and Tc/s (1250 +/- 273) in 13 of 38 patients compared with control patients (Th 484 +/- 129 and Tc/s 460 +/- 166). The RAD-DR on Tc/s correlated with the relative ICA titer and was greatest on DR3/4-phenotyped T-lymphocytes. In addition, significantly increased RAD-DR was found in noncontrol patients with impaired insulin release responses at 1 and 3 min to intravenous glucose.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0012-1797
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1416-22
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3533686-Adolescent,
pubmed-meshheading:3533686-Adult,
pubmed-meshheading:3533686-Antibodies,
pubmed-meshheading:3533686-Autoimmune Diseases,
pubmed-meshheading:3533686-B-Lymphocytes,
pubmed-meshheading:3533686-Child,
pubmed-meshheading:3533686-Diabetes Mellitus, Type 1,
pubmed-meshheading:3533686-Female,
pubmed-meshheading:3533686-Flow Cytometry,
pubmed-meshheading:3533686-HLA-DR Antigens,
pubmed-meshheading:3533686-Humans,
pubmed-meshheading:3533686-Islets of Langerhans,
pubmed-meshheading:3533686-Lymphocyte Activation,
pubmed-meshheading:3533686-Lymphocytes,
pubmed-meshheading:3533686-Male,
pubmed-meshheading:3533686-Prediabetic State,
pubmed-meshheading:3533686-T-Lymphocytes
|
pubmed:year |
1986
|
pubmed:articleTitle |
Lymphocyte subsets and activation in prediabetes.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|